eNauka - pregled
Pregled prema Projekat Biogen (Cambridge, MA, USA)
Prikaz rezultata 1 do 4 od 4
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2019 | Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: interim safety and efficacy results from the Phase 3 EVOLVE-MS-1 study | Bergh, Florian Then; Singer, BA; Drulović, Jelena S.  ; Bidollari, I.; Chen, Hailu; Englishby, R.; Hanna, Jerome; Kandinov, Boris; Lopez-Bresnahan, Maria; Leigh-Pemberton, Richard;
Miller, Catherine; Mokliatchouk, O.; Shafer, SJ;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2020 | Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study | Naismith, Robert T; ...; Obradovic, Dragana V; ...; (broj, koautora 20) | Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
| 2016 | Efficacy analysis of opicinumab in relapsing multiple sclerosis: the Phase 2b SYNERGY trial | Cadaviv, Diego; Edwards, KR; Hupperts, Raymond; Drulović, Jelena S. ; Montalban, Xavier; Hartung, HP; Brochet, B.; Calabresi, PA; Rudick, R.; Ibrahim, Adama;
Zhang, Yiwei; Xu, Lei;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2022 | Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study | Wray, Sibyl; ...; Drulović, Jelena S. ; ...; (broj koautora 17) | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |